Limari, April .
HRN: 25-18-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2024
CEFUROXIME 750MG (VIAL)
06/13/2024
06/19/2024
IVT
1.5g Ivt Ld Then 750mg
Q8hrs
Incomplete Abortion
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: Yes
Overall appropriateness: Yes